BCL2 and acute lymphoblastic leukemia: Asynchronous ALL-5 cells treated with the Bcl-2 inhibitor ABT-263 were used as a positive control, and DNA fragmentation was assessed by sub-G1 DNA content after propidium iodide staining and flow cytometry.